Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deborah Ashby

Showing results (121-130 of 128) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 128 results.
Thorax|February 12, 2013
Changes in physiological, functional and structural markers of cystic fibrosis lung disease with treatment of a pulmonary exacerbationAlex R Horsley, Jane C Davies, Robert D Gray, et al.
Eclinicalmedicine|January 29, 2025
CONSORT-DEFINE explanation and elaboration: recommendations for enhancing reporting quality and impact of early phase dose-finding clinical trialsJan Rekowski, Christina Guo, Olga Solovyeva, et al.
Eclinicalmedicine|January 29, 2025
SPIRIT-DEFINE explanation and elaboration: recommendations for enhancing quality and impact of early phase dose-finding clinical trials protocolsMoreno Ursino, Guillermo Villacampa, Jan Rekowski, et al.
Thorax|August 16, 2020
Clinical and laboratory evaluation of SARS-CoV-2 lateral flow assays for use in a national COVID-19 seroprevalence surveyBarnaby Flower, Jonathan C Brown, Bryony Simmons, et al.
Lancet (London, England)|September 29, 2009
Challenges in evaluating surgical innovationPatrick L Ergina, Jonathan A Cook, Jane M Blazeby, et al.
Lancet (London, England)|September 29, 2009
Evaluation and stages of surgical innovationsJeffrey S Barkun, Jeffrey K Aronson, Liane S Feldman, et al.
Lancet (London, England)|September 29, 2009
No surgical innovation without evaluation: the IDEAL recommendationsPeter McCulloch, Douglas G Altman, W Bruce Campbell, et al.
The Lancet. Respiratory Medicine|July 8, 2015
Repeated nebulisation of non-viral CFTR gene therapy in patients with cystic fibrosis: a randomised, double-blind, placebo-controlled, phase 2b trialEric W F W Alton, David K Armstrong, Deborah Ashby, et al.
Pageof 13

Showing results (121-130 of 128) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 128 results.
Thorax|February 12, 2013
Changes in physiological, functional and structural markers of cystic fibrosis lung disease with treatment of a pulmonary exacerbationAlex R Horsley, Jane C Davies, Robert D Gray, et al.
Eclinicalmedicine|January 29, 2025
CONSORT-DEFINE explanation and elaboration: recommendations for enhancing reporting quality and impact of early phase dose-finding clinical trialsJan Rekowski, Christina Guo, Olga Solovyeva, et al.
Eclinicalmedicine|January 29, 2025
SPIRIT-DEFINE explanation and elaboration: recommendations for enhancing quality and impact of early phase dose-finding clinical trials protocolsMoreno Ursino, Guillermo Villacampa, Jan Rekowski, et al.
Thorax|August 16, 2020
Clinical and laboratory evaluation of SARS-CoV-2 lateral flow assays for use in a national COVID-19 seroprevalence surveyBarnaby Flower, Jonathan C Brown, Bryony Simmons, et al.
Lancet (London, England)|September 29, 2009
Challenges in evaluating surgical innovationPatrick L Ergina, Jonathan A Cook, Jane M Blazeby, et al.
Lancet (London, England)|September 29, 2009
Evaluation and stages of surgical innovationsJeffrey S Barkun, Jeffrey K Aronson, Liane S Feldman, et al.
Lancet (London, England)|September 29, 2009
No surgical innovation without evaluation: the IDEAL recommendationsPeter McCulloch, Douglas G Altman, W Bruce Campbell, et al.
The Lancet. Respiratory Medicine|July 8, 2015
Repeated nebulisation of non-viral CFTR gene therapy in patients with cystic fibrosis: a randomised, double-blind, placebo-controlled, phase 2b trialEric W F W Alton, David K Armstrong, Deborah Ashby, et al.
Pageof 13